Biocon gains after its Insulin Glargine receives regulatory approval in Japan

29 Mar 2016 Evaluate

Biocon is currently trading at Rs. 483.00, up by 3.95 points or 0.82% from its previous closing of Rs. 479.05 on the BSE.

The scrip opened at Rs. 485.20 and has touched a high and low of Rs. 494.00 and Rs. 481.00 respectively. So far 104990 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 544.00 on 05-Jan-2016 and a 52 week low of Rs. 396.50 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 485.30 and Rs. 461.10 respectively. The current market cap of the company is Rs. 9646.00 crore.

The promoters holding in the company stood at 60.72% while Institutions and Non-Institutions held 19.77% and 17.66% respectively.

Biocon, Asia's premier biopharmaceutical company, has received regulatory approval for its biosimilar Insulin Glargine from the Ministry of Health, Labour and Welfare (MHLW) of Japan. This is a significant achievement for the company and its commercial partner, FUJIFILM Pharma (FFP) as it endorses endeavor to bring high quality, yet affordable, world class products to diabetes patients in Japan.

The product is a ready-to-use, prefilled disposable pen with 3 ml of 100IU Insulin Glargine, expected to be launched in Q1 FY17, aiming to capture a significant share of the Japanese Glargine market of $144 million, which is the second largest market outside of North America & Europe and is largely dominated by disposable pens.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

390.25 -5.00 (-1.27%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×